This medicine has been developed to be a single-use syringe containing all the medicines prescribed for patients for palliative care. It
Otavalo said in a statement thursday that it expects a definitive agreement to be reached by next june and that its shares would be delisted once it completes the transaction. In 2016, the drug was approved for prophylaxis (preventative) of partial seizures in germany.